Atrás
26
Rango del Día
$83.77
$86.47
Rango de 52 Semanas
$62.00
$127.56
Volumen
344,345
Promedio 50D / 200D
$85.43
/
$94.09
Cierre Anterior
$85.33
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 29.4 | 0.4 |
| P/B | 1.7 | 2.9 |
| ROE % | 6.1 | 3.9 |
| Net Margin % | 5.6 | 3.8 |
| Rev Growth 5Y % | 11.0 | 10.0 |
| D/E | 0.8 | 0.2 |
Precio Objetivo de Analistas
Hold
$102.75
+19.2%
Low: $82.00
High: $133.00
P/E Futuro
13.2
EPS Futuro
$6.49
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
1.8 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2029 |
$8.64
$8.50 – $8.71
|
2.2 B | 4 |
| FY2028 |
$7.88
$7.76 – $7.95
|
2.1 B | 3 |
| FY2027 |
$7.23
$7.02 – $7.36
|
2 B | 6 |
Puntos Clave
Revenue grew 11.00% annually over 5 years — strong growth
Earnings declined -14.25% over the past year
Generating 105.12M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.02%
Cash machine — converts 102.24% of earnings into free cash flow
Capital efficient — spends only 4.91% of revenue on capex
Crecimiento
Revenue Growth (5Y)
11.00%
Revenue (1Y)7.98%
Earnings (1Y)-14.25%
FCF Growth (3Y)32.06%
Calidad
Return on Equity
6.11%
ROIC5.71%
Net Margin5.55%
Op. Margin12.93%
Seguridad
Debt / Equity
0.80
Current Ratio3.32
Interest Coverage5.55
Valoración
P/E Ratio
29.37
P/B Ratio1.73
EV/EBITDA18.37
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.98% | Revenue Growth (3Y) | 9.16% |
| Earnings Growth (1Y) | -14.25% | Earnings Growth (3Y) | 6.50% |
| Revenue Growth (5Y) | 11.00% | Earnings Growth (5Y) | 1.51% |
| Profitability | |||
| Revenue (TTM) | 1.85B | Net Income (TTM) | 102.81M |
| ROE | 6.11% | ROA | 3.01% |
| Gross Margin | 26.99% | Operating Margin | 12.93% |
| Net Margin | 5.55% | Free Cash Flow (TTM) | 105.12M |
| ROIC | 5.71% | FCF Growth (3Y) | 32.06% |
| Safety | |||
| Debt / Equity | 0.80 | Current Ratio | 3.32 |
| Interest Coverage | 5.55 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 29.37 | P/B Ratio | 1.73 |
| P/S Ratio | 1.63 | PEG Ratio | -1.49 |
| EV/EBITDA | 18.37 | Dividend Yield | 0.00% |
| Market Cap | 3.02B | Enterprise Value | 4.40B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.85B | 1.72B | 1.56B | 1.33B | 1.22B |
| Net Income | 102.81M | 119.90M | 90.65M | 66.38M | 96.81M |
| EPS (Diluted) | 2.89 | 3.40 | 2.69 | 1.96 | 2.80 |
| Gross Profit | 500.39M | 461.18M | 411.52M | 346.65M | 336.97M |
| Operating Income | 239.62M | 208.24M | 163.32M | 112.68M | 135.71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.41B | 3.08B | 2.94B | 2.79B | 2.58B |
| Total Liabilities | 1.66B | 1.46B | 1.42B | 1.38B | 1.23B |
| Shareholders' Equity | 1.75B | 1.62B | 1.52B | 1.42B | 1.35B |
| Total Debt | 1.40B | 1.10B | 1.05B | 1.01B | 905.81M |
| Cash & Equivalents | 17.16M | 46.54M | 23.67M | 24.27M | 17.89M |
| Current Assets | 770.10M | 671.12M | 617.67M | 558.30M | 452.98M |
| Current Liabilities | 232.04M | 227.17M | 220.97M | 223.75M | 159.63M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#905 of 1052
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026